Compound ID | 140
Synonym(s): WCK 4873
Class: Macrolide
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Binds to domains II and V of 23S rRNA to circumvent resistance mechanisms impacting older macrolide due to their single target binding |
| Target Pathogen: | Active against pathogen causing community-acquired bacterial pneumonia |
| Description: | A 16-membered macrolide/ ketolide; derivative of clarithromycin |
| Institute where first reported: | Wockhardt, India |
| Year first mentioned: | 2013 |
| Highest development stage: | Approved in India |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/117587595 |
| Guide to Pharmacology: | nafithromycin |
| Citations: |
|